Julia Hoeng

Julia Hoeng has a diverse work experience in the field of research and development. Julia currently holds the position of VP Cannabinoid Innovation and Product Development at Vectura Fertin Pharma. Prior to this, they served as the Chief Innovation Officer and Chief External Innovation Officer at the same company.

Julia has also worked at Philip Morris International, where they held various roles including Global Head Discovery Life Sciences, Director Systems Toxicology, Manager Systems Toxicology, Manager Computational Disease Biology, and Specialist R&D Risk Assessment. In these roles, they led multidisciplinary scientific teams and managed strategic projects related to product testing and research methodologies.

Earlier in their career, Julia worked as a PhD/PostDoc Researcher in Protein Crystallography at the Medical Research Council - Laboratory of Molecular Biology, as a Bioinformatics Industrial Fellow at Merck Research Laboratories, and as a Graduate Student Research Assistant at Georgia Tech.

Overall, Julia Hoeng has demonstrated expertise in innovation, product development, toxicology, systems biology, and research in various scientific domains throughout their career.

Julia Hoeng's education history includes an Executive MBA from Business School Lausanne (BSL) in 2011-2012. Julia also completed a program in Strategic Leadership for Women at IMD in 2010. Prior to that, they obtained a PhD in Protein Crystallography from the University of Cambridge in 2003-2006, and an MS in Bioinformatics from the Georgia Institute of Technology in 2001-2003. Julia Hoeng earned their Bachelor of Science degree with a major in Biology and minors in Chemistry and Mathematics from Guilford College in 1997-2000. Julia also completed their high school education at an undisclosed institution and attended Pater Rupert Mayer Gymnasium, although no specific dates were provided for these two institutions.